Publications

 

Feil L*, Koch A*, Utz R, Ackermann M, Barz J, Stope M, Krämer B, Wallwiener D, Brucker SY, Weiss M. Cancer-Selective Treatment of Cancerous and Non-Cancerous Human Cervical Cell Models by a Non-Thermally Operated Electrosurgical Argon Plasma Device. Cancers 2020, 12, 1037. https://doi.org/10.3390/cancers12041037
Impact: 6,13

Daum R, Visser D, Wild C, Kutuzova L, Schneider M, Lorenz G, Weiss M, Hinderer S, Stock UA, Seifert M, Schenke-Layland K. Fibronectin adsorption on electrospun synthetic vascular grafts attracts endothelial progenitor cells and promotes endothelialization in dynamic in vitro culture. Cells 2020, 9(3), 778; doi:10.3390/cells9030778

Wenzel T, Carvajal Berrio DA, Reisenauer C, Layland S, Koch A, Wallwiener D, Brucker SY, Schenke-Layland K, Brauchle EM, Weiss M. Trans-Mucosal Efficacy of Non-Thermal Plasma Treatment on Cervical Cancer Tissue and Human Cervix Uteri by a Next Generation Electrosurgical Argon Plasma Device. Cancers 2020, 12, 267; doi:10.3390/cancers12020267

Wenzel T, Carvajal Berrio D, Daum R, Reisenauer C, Weltmann KD, Wallwiener D, Brucker S, Schenke-Layland K, Brauchle EM*, Weiss M*. Molecular Effects and Tissue Penetration Depth of Physical Plasma in Human Mucosa Analyzed by Contact- and Marker-Independent Raman Microspectroscopy. ACS Applied Materials & Interfaces 2019 Nov 20;11(46):42885-42895. doi: 10.1021/acsami.9b13221

Weiss M, Barz J, Ackermann M, Utz R, Ghoul A, Weltmann KD, Stope MB, Wallwiener D, Schenke-Layland K, Oehr C, Brucker S, Loskill P. Dose-Dependent Tissue-Level Characterization of a Medical Atmospheric Pressure Argon Plasma Jet. ACS Applied Materials & Interfaces. 2019 Jun 5;11(22):19841-19853. Doi: 10.1021/acsami.9b04803.

Weiss M*, Stope MB*, Popp SL, Joffroy C, Wallwiener D, Brucker SY, Mustea A, Buck MB, Knabbe C. The pleiotropic factor Y-box binding protein-1 enhances the anti-proliferative efficacy of 4-hydroxytamoxifen and fulvestrant on breast cancer cells in vitro. Eur. J. Gynaecol. Oncol. 2019 doi: 10.12892/ejgo4282.2019.

Hoffmann SM, Kappel D, Fech A, Enderle MD, Weiss M, Hahn M, Brucker SY, Kraemer B. Thermal effects of a novel electrosurgical device for fucused preparation in breast surgery tested in a specified porcine tissue ex vivo breast model using infrared measurement. Arch Gynecol Obstet (2019) 299:835-840 doi: 10.1007/s00404-018-5024-x

Weiss M, Utz R, Ackermann M, Taran FA, Krämer B, Hahn M, Wallwiener D, Brucker S, Haupt M, Barz J, Oehr C. Characterization of a non‐thermally operated electrosurgical argon plasma source by electron spin resonance spectroscopy. Plasma Proc. Polym. 2018 10.1002/ppap.201800150

Simoes E, Graf J, Sokolov AN, Grischke EM, Hartkopf AD, Hahn M, Weiss M, Abele H, Seeger H, Brucker SY. Pregnancy-associated breast cancer: maternal breast cancer survival over 10 years and obstetrical outcome at a university centre of women’s health. Arch Gynecol Obstet. 2018. doi: 10.1007/s00404-018-4822-5.

Weiss M*, Koensgen D*, Assmann K, Brucker SY, Wallwiener D, Stope MB, Mustea A. Characterization and Management of Borderline Ovarian Tumors – Results of a Retrospective, Single-center Study of Patients Treated at the Department of Gynecology and Obstetrics of the University Medicine Greifswald. Anticancer res. 2018; 38: 1539-1545.

Weiss M*, Stope MB*, Popp SL, Joffroy C, Mustea A, Buck MB, Knabbe C. Y-box binding protein-1 enhances oncogenic transforming growth factor β signaling in breast cancer cells via triggering phospho-activation of Smad2. Anticancer res. 2017; 37:6745-6748.

Koensgen D, Besic I, Gümbel D, Kaul A, Weiss M, Diesing K, Kramer A, Bekeschuss S, Mustea A, Stope MB. Cold Atmospheric Plasma (CAP) and CAP-Stimulated Cell Culture Media Suppress Ovarian Cancer Cell Growth – A Putative Treatment Option in Ovarian Cancer Therapy. Anticancer res. 2017; 37: 6739-6744.

Koensgen D, Sehouli J, Belau A, Weiss M, Stope MB, Großkopf V,  Eichbaum M, Lewdon P, Lichtenegger W, Zygmunt M, Köhler G, Mustea A. Clinical Outcome of Neoadjuvant Radiochemotherapy in Locally Advanced Cervical Cancer: Results of an open prospective, multicenter phase 2 study of the North-Eastern Society of Gynaecological Oncology. Int J Gynecol Cancer. 2017, 27 :500-506.

Gümbel D, Gelbrich N, Weiss M, Daeschlein G, Sckell A, Ender SA, Kramer A, Burchardt M, Ekkernkamp A, Stope MB. New Treatment Options for Osteosarcoma – Inactivation of Osteosarcoma Cells by Cold Atmospheric Plasma. Anticancer Research 2016, 36:5915-5922.

Weiss M, Ahrend H, Grossebrummel H, Ziegler P, Brandenburg LO, Walther R, Zimmermann U, Burchardt M, Stope MB. Cytochrome P450 17A1 Inhibitor Abiraterone Acetate Counteracts the Heat Shock Protein 27’s Cell Survival Properties in Prostate Cancer Cells. Urol Int. 2016;97(1):112-7.

Stope MB, Wiegank L, Weiss M, Diesing K, Koensgen D, Burchardt M, Zygmunt M, Mustea A. Drug-induced modulation of heat shock protein 27 in an ovarian cancer cell model. Anticancer Res. 2016 36(7):3321-7.

Robert Mandelkow, Daniela Brünnert, Weiss M, Dominique Koensgen, Martin Burchardt, Marek Zygmunt, Alexander Mustea, Matthias B. Stope. Lysophosphatidic acid receptor isoforms expression in prostate cancer cells is differentially regulated by the CYP17A1 inhibitor abiraterone and depends on the androgen receptor. Adv Mod Oncol Res 2016  2(1).

Großebrummel H, Peter T, Mandelkow R, Weiss M, Muzzio D, Zimmermann U, Walther R, Jensen F, Knabbe C, Zygmunt M, Burchardt M, Stope MB. Cytochrome P450 17A1 inhibitor abiraterone attenuates cellular growth of prostate cancer cells independently from the androgen receptor. Int J Oncol. 2016 Feb;48(2):793-800.
IF: 3,079

Weiss M, Gümbel D, Gelbrich N, Brandenburg LO, Mandelkow R, Zimmermann U, Ziegler P, Burchardt M, Stope MB. Inhibition of Cell Growth of the Prostate Cancer Cell Model LNCaP by Cold Atmospheric Plasma. In Vivo. 2015 09-10;29(5):611-616.

Weiss M, Gümbel D, Hanschmann EM, Mandelkow R, Gelbrich N, Zimmermann U, Walther R, Ekkernkamp A, Sckell A, Kramer A, Burchardt M, Lillig CH, Stope MB. Cold Atmospheric Plasma Treatment Induces Anti-Proliferative Effects in Prostate Cancer Cells by Redox and Apoptotic Signaling Pathways. PLoS One. 2015 10:e0130350.

Weiss M*, Stope MB*, Preuss M, Streitbörger A, Ritter CA, Zimmermann U, Walther R, Burchardt M. Immediate and transient phosphorylation of the heat shock protein 27 initiates chemoresistance in prostate cancer cells. Oncol Rep. 2014 32:2380-6

Stope MB, Stender C, Schubert T, Peters S, Weiss M, Ziegler P, Zimmermann U, Walther R, Burchardt M. Heat-shock Protein HSPB1 Attenuates MicroRNA miR-1 Expression Thereby Restoring Oncogenic Pathways in Prostate Cancer Cells. Anticancer Res. 2014 34:3475-80

Stope MB, Bradl J, Peters S, Streitbörger A, Weiss M, Zimmermann U, Walther R, Lillig CH, Burchardt M. Shortened isoforms of the androgen receptor are regulated by the cytoprotective heat-shock protein HSPB1 and the tumor-suppressive microRNA miR-1 in prostate cancer cells. Anticancer Res. 2013 33:4921-6

Reviews

Grube M, Neis F, Brucker SY, Kommoss S, Andress J, Weiss M, Hoffmann S, Taran FA, Krämer B. Uterine Fibroids – Current Trends and Strategies. Surgical Technology International 2019 34

Nawroth J, Rogal J, Weiss M, Brucker SY, Loskill P. Organ-on-a-Chip Systems for Women’s Health Applications. Adv Healthc Mater 2018; 7.

Weiss M, Daeschlein G, Kramer A, Burchardt M, Brucker S, Wallwiener D, Stope MB. Virucide properties of cold atmospheric plasma for future clinical applications. J Med Virol 2017 89:952-959

Weiss M, Brandenburg LO, Burchardt M, Stope MB. MicroRNA-1 properties in cancer regulatory networks and tumor biology. Crit Rev Oncol Hematol. 2016 104:71-7.